Stay updated with breaking news from Fred Schwarzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price traded down 6% during mid-day trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. 40,803 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 310,863 shares. The stock had previously closed […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price traded down 6% during mid-day trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. 40,803 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 310,863 shares. The stock had previously closed […]
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) have received an average recommendation of “Hold” from the nine research firms that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price […]
MOUNTAIN VIEW, Calif., Feb. 01, 2024 -- IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief...
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has earned an average recommendation of “Hold” from the nine analysts that are covering the company, MarketBeat reports. Six analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year price objective among brokers that […]